Peak Financial Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Buy
981
+50
+5% +$10.8K 0.06% 97
2026
Q1
$202K Sell
931
-33
-3% -$7.32K 0.05% 98
2025
Q4
$220K Sell
964
-100
-9% -$22.8K 0.06% 94
2025
Q3
$247K Buy
+1,064
New +$217K 0.07% 83
2025
Q2
Sell
-1,004
Closed -$211K 96
2025
Q1
$211K Sell
1,004
-250
-20% -$48.6K 0.06% 91
2024
Q4
$223K Buy
1,254
+90
+8% +$16.5K 0.07% 90
2024
Q3
$230K Sell
1,164
-84
-7% -$15.7K 0.07% 90
2024
Q2
$214K Sell
1,248
-26
-2% -$4.31K 0.07% 89
2024
Q1
$232K Buy
+1,274
New +$220K 0.07% 86

Other funds holding ABBV

Peak Financial Management's ABBV Position: Q2 2026 in Review

Peak Financial Management increased its AbbVie (ABBV) stake by 5.4% in Q2 2026, buying an estimated $10.8K and bringing the position to 981 shares worth $247K. The position accounts for 0.06% of the portfolio, ranked #97.

Peak Financial Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Peak Financial Management held 981 shares of AbbVie worth $247K as of Q2 2026.
  • Peak Financial Management bought 50 AbbVie shares in Q2 2026, an estimated $10.8K.
  • AbbVie made up 0.06% of Peak Financial Management's portfolio in Q2 2026, its #97 holding.
  • Peak Financial Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Peak Financial Management's 13F filing for Q2 2026, filed 20 Jul 2026.